Related Experiment Video
Updated: Aug 9, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents
1Department of Biomolecular Science and Biotechnology, University of Milan, Italy. dario.difrancesco@unimi.it
Current Medical Research and Opinion
|July 12, 2005
Summary
The funny (I(f)) current in pacemaker cells controls heart rate. Specific inhibitors like ivabradine target these channels, offering a new way to regulate cardiac rate.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- The funny (I(f)) current, identified in pacemaker myocytes, is crucial for spontaneous heart activity.
- I(f) current activation influences diastolic depolarization slope and thus pacemaker rate.
- This current is modulated by cyclic adenosine monophosphate (cAMP) via beta-adrenergic and muscarinic signaling, impacting cardiac rate regulation.
Purpose of the Study:
- To review the fundamental properties of cardiac f-channels.
- To focus on the mechanism of action of f-channel inhibitors.
- To explore the molecular basis of f-channel inhibition for improved drug design.
Main Methods:
- Review of existing literature on I(f) current and f-channel inhibitors.
- Analysis of the 'use-dependent' inhibitory action of ivabradine.
- Discussion of hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels as molecular targets.
Main Results:
- I(f) current is essential for pacemaking and is modulated by neurotransmitters.
- Specific f-channel inhibitors decrease diastolic depolarization, reducing heart rate.
- Ivabradine exhibits a unique, use-dependent inhibition of I(f) channels.
Conclusions:
- I(f) channels are key targets for modulating cardiac rate.
- Understanding the interaction between drugs and HCN channels can lead to better drug development.
- Ivabradine's specific properties offer therapeutic advantages in heart rate regulation.
Related Concept Videos
01:21G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
01:19Electrophysiology of Normal Cardiac Rhythm
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...